Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
39 studies found for:    "Lynch syndrome"
Show Display Options
Rank Status Study
21 Active, not recruiting Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
Conditions: Colon Mucinous Adenocarcinoma;   Colon Signet Ring Cell Adenocarcinoma;   Lynch Syndrome;   Stage IIA Colon Cancer;   Stage IIB Colon Cancer;   Stage IIC Colon Cancer
Interventions: Drug: Oxaliplatin;   Drug: Leucovorin Calcium;   Drug: Fluorouracil;   Biological: Bevacizumab;   Other: Laboratory Biomarker Analysis
22 Completed Telemedicine vs. Face-to-Face Cancer Genetic Counseling
Conditions: Hereditary Breast and Ovarian Cancer Syndrome;   Lynch Syndrome
Interventions: Other: Telemedicine;   Other: Face-to-Face
23 Completed Magnification Narrow Band Imaging Colonoscopy for Hereditary Non-Polyposis Colorectal Cancer Surveillance
Condition: Colorectal Neoplasms, Hereditary Nonpolyposis
Intervention: Procedure: Narrow Band Imaging
24 Recruiting The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)
Conditions: Bladder Cancer;   Colorectal Cancer;   Endometrial Cancer;   Kidney Cancer;   Skin Cancer;   Uterus Cancer
Intervention: Behavioral: Health and Diet Questionnaire
25 Active, not recruiting Screening for Gynecologic Cancers in Hereditary Nonpolyposis Colorectal Cancer (HNPCC) Patients
Condition: Colon Cancer
Intervention: Behavioral: Questionnaire
26 Unknown  Collecting Information From Patients and Family Members With Hereditary Colorectal Cancer Syndromes or Who Are at High Risk of Developing Colorectal Cancer
Conditions: Colorectal Cancer;   Hereditary Nonpolyposis Colorectal Cancer;   Precancerous Condition
Interventions: Other: study of socioeconomic and demographic variables;   Procedure: evaluation of cancer risk factors;   Procedure: study of high risk factors
27 Unknown  Biomarkers in Samples From Patients With Endometrial Cancer
Conditions: Endometrial Cancer;   Hereditary Non-polyposis Colon Cancer
Interventions: Genetic: DNA analysis;   Genetic: DNA methylation analysis;   Genetic: gene expression analysis;   Genetic: molecular genetic technique;   Genetic: mutation analysis;   Genetic: polymorphism analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Genetic: western blotting;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis
28 Completed
Has Results
Educational CD-ROM Compared With Standard Informed Consent for Patients With Colorectal Cancer or a Family History of Colorectal Cancer
Conditions: Colorectal Cancer;   Hereditary Non-polyposis Colon Cancer
Interventions: Other: counseling intervention;   Other: CD-ROM intervention
29 Completed Attitudes Towards Prophylactic Colectomy in Hereditary Non-polyposis Colorectal Cancer (HNPCC) Patients
Condition: Colorectal Cancer
Intervention: Other: Telephone survey
30 Completed CHROENDOHNPCC: Early Detection of Pre-cancer Lesions in Adults With Hereditary Nonpolyposis Colorectal Cancer Syndrome
Condition: Colorectal Neoplasms, Hereditary Nonpolyposis
Intervention: Procedure: Colonoscopy with chromoscopy
31 Recruiting Dendritic Cell Vaccination in Patients With Lynch Syndrome or Colorectal Cancer With MSI
Condition: Colorectal Cancer
Intervention: Biological: DC vaccination
32 Completed Study of the Results of Education and Counseling for Persons Undergoing Genetic Testing for Hereditary Nonpolyposis Colon Cancer
Condition: Colorectal Cancer
Interventions: Other: loss of heterozygosity analysis;   Other: microsatellite instability analysis;   Other: mutation analysis;   Other: counseling intervention
33 Completed Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer
Condition: Endometrial Cancer
Interventions: Drug: medroxyprogesterone;   Drug: ethinyl estradiol;   Drug: norgestrel;   Other: laboratory biomarker analysis
34 Completed Phase I-II Multiple-Dose Safety and Efficacy Study of a Selective Inhibitor of Cyclooxygenase - 2 (SC-58635) in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients and Carriers
Conditions: Colorectal Neoplasm;   Hereditary Nonpolyposis
Intervention: Drug: Celecoxib (SC-58635)
35 Active, not recruiting Combined Colon and Endometrial Cancer Screening in Women With HNPCC
Condition: Colon Cancer
Intervention: Behavioral: Interview
36 Recruiting A Social Media Approach to Improve Genetic Risk Communication Phase I
Condition: Hereditary Diseases
Interventions: Behavioral: Audiotaped Focus Group;   Behavioral: Demographic Questionnaire;   Behavioral: Audiotaped Interview;   Behavioral: WAMMI Inventory
37 Recruiting Ileal Pouch-Anal Anastomosis Registry
Condition: Ileal Pouch-Anal Anastomosis
Intervention:
38 Recruiting Adherence to Colon Cancer Screening (ACCS)
Conditions: Colon Cancer;   Rectal Cancer
Intervention: Other: Patient Navigator
39 Unknown  Establishing Effective Screening Methods for Diagnosing Hereditary Nonpolypoisis Colorectal Cancer
Condition: Colonic Neoplasms
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-39) Next Page   
Indicates status has not been verified in more than two years